Imposing Phase II and Phase III Clinical Trials of Targeted Drugs for Glioblastoma: Current Status and Progress.

Front Oncol · 2021 · PMC8458950 · PMID 34568049

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The study failed to reach the expected outcomes in PFS and OS, though it showed a trend toward efficacy in subgroups of unmethylated MGMT promoter patients.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.